Health Care·Pharmaceuticals·$17.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.33 | N/A | -59.01% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.33 | N/A | -59.01% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about market conditions affecting performance. They did not provide any forward guidance for the upcoming quarters.
Management acknowledged the challenges faced during the quarter.
There was no specific guidance provided for future performance.
Viatris Inc reported a lower-than-expected EPS for the quarter, which typically raises concerns among investors. However, the stock reacted positively, increasing by 5.33%. This could indicate that investors are optimistic about other aspects of the business or future potential despite the EPS miss.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
NRG ENERGY INC
May 6, 2022